muramylnac-ala-isogln-lys-tripeptide has been researched along with ribavirin in 1 studies
| Studies (muramylnac-ala-isogln-lys-tripeptide) | Trials (muramylnac-ala-isogln-lys-tripeptide) | Recent Studies (post-2010) (muramylnac-ala-isogln-lys-tripeptide) | Studies (ribavirin) | Trials (ribavirin) | Recent Studies (post-2010) (ribavirin) |
|---|---|---|---|---|---|
| 50 | 4 | 1 | 12,316 | 1,880 | 5,443 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnhart, D; Gangemi, JD; Jani, P; Krech, L; Nachtigal, M | 1 |
1 other study(ies) available for muramylnac-ala-isogln-lys-tripeptide and ribavirin
| Article | Year |
|---|---|
Therapeutic efficacy of liposome-encapsulated ribavirin and muramyl tripeptide in experimental infection with influenza or herpes simplex virus.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Drug Therapy, Combination; Herpes Simplex; Liposomes; Macrophage Activation; Macrophages; Mice; Mice, Inbred C3H; Orthomyxoviridae Infections; Phagocytosis; Pneumonia, Viral; Ribavirin; Ribonucleosides | 1987 |